Arterys Inc: Business Overview, Financials & Competitive Analysis
Arterys is a cloud-based AI platform for medical imaging analysis that integrates clinical applications into existing workflows, enhancing diagnostic decision-making. The company was acquired by Tempus in November 202...
Cyborg Score thesis
Acquired medical imaging AI player with validated clinical applications and enterprise scale potential through Tempus...
Read the full analyst-debate transcript →Get the Latest Arterys Inc Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeArterys Inc Overview
Pro stress-test →Arterys is a cloud-based AI platform for medical imaging analysis that integrates clinical applications into existing workflows, enhancing diagnostic decision-making. The company was acquired by Tempus in November 2022 and now operates as Tempus Radiology.
Strategic Profile
Pro stress-test →The platform aims to improve physician experience, diagnostic accuracy, treatment, financial performance, and patient outcomes. Arterys' product has been integrated into Tempus' solutions, enabling providers to access a comprehensive patient view inclusive of radiology scans and researchers to leverage this data modality to optimize the drug development process.
Competitive Landscape
Pro stress-test →Arterys competes with HeartFlow, Cleerly, and Lantheus. The competitive landscape in AI Medical Imaging features major firms like GE Healthcare, Siemens Healthineers, and Philips, alongside players like Aidoc. Competitive differentiation is expected through model explainability, clinical validation, and adoption of open AI platforms.
Industry Context
Arterys Inc operates in Diagnostic Imaging Equipment.
Key facts
Founded: 2012 · Headquarters: San Francisco, US